Cargando…
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
B-cell lymphoma 9 (BCL9), a component of aberrantly activated Wnt signaling, is an important contributing factor to tumor progression. Our previous data indicated that downregulation of the tumor suppressor microRNA-30c (miR-30c) was a frequent pathogenetic event in prostate cancer (PCa). However, a...
Autores principales: | LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774446/ https://www.ncbi.nlm.nih.gov/pubmed/26998113 http://dx.doi.org/10.3892/ol.2016.4161 |
Ejemplares similares
-
Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2
por: Sinha, Abhishek, et al.
Publicado: (2021) -
The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008) -
Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2017) -
Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling
por: Wendt, Mathias, et al.
Publicado: (2021) -
Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling
por: Tao, Bei, et al.
Publicado: (2021)